Share prices of marijuana companies have soared since their debuts. Prices are now at a critical point. New investors are being lured into the world's largest casino - the stock market - and that is a red flag for money managers.
On Wednesday November 16, 2016, six major marijuana stocks tripped circuit breakers on the Toronto Stock Exchange after spiking up at least 10% in five minutes. Circuit breakers were put in place to prevent unusual trading patterns from continuing in either direction. This triggers a halt, which can last as little as a five minutes or as long as the remainder of the day, and allows traders and investors an intermission to re-examine the price movements and prevent panic selling or irrational buying.
However, the major moves seen on Wednesday, with stocks opening as much as 44 per cent higher then losing all of their gains in an hour and continuing to fall further, indicates that support in prices has left the building. We are in a gambler's environment that risk intolerant traders should highly avoid. Although there will always be opportunities to make money, it appears it will be out of luck and not proper timing. A person that purchased shares on Wednesday morning would have lost half their investment before the trading day had ended. The inability of novice investors to understand irrational exuberance cannot be understated. Momentum is a greedy and risky game that always ends up in losses for the last man because the well of buyers eventually dries up.
History often shows that a mass entrance into an asset class coupled with significant volatility may well be the final period of upward momentum - the end of a bubble as they say. In this century, we have seen speculators hop onto the bandwagon of uranium, silver, potash, Bitcoin, and Internet stocks, just to name a few. The prices of most of these assets have broken down from their highs coinciding with similar mainstream euphoria we are currently observing. And major companies like Microsoft took 15 years to re-reach those prices.
Supported by the belief that regulatory bodies in Canada and the US will provide better access to marijuana and increase sales, as valid and factual as that may be, what many novice traders are ignorant of is proper valuation. On Wednesday, for a brief moment in time, Canopy Growth was worth $2 billion, doubling its value from Friday, which was also a record high.
The unicorn of the industry, earned $12 million Canadian in revenue over the last 12 months with a net loss of $3.5 million. Penny stocks are very hard to valuate because their projected growth in revenue are unlimited. In a decade, it is highly possible for this company to be generating over $100 million annually. Once it reaches maturity, to maintain its $1 bilion market cap, it would have to generate at least half a million in revenue per year or offer net income of around $100 to $200 million. Essentially, if you purchased the stock today, the company would need to grow sales more than 40 times to more accurately justify its current price. That's not to say the price won't climb to fresh highs. Growth companies are given heavy premiums, but long-term investors won't be finding any deals in the near future.
The industry itself is growing and the drug is more accepted. Money always trumps morals as some would argue, but governments acknowledge the reality that weed is a money-making machine, and there's a reason why so many gangs and illegal producers have lobbied to prevent and oppose its legalization. The truth is that these companies will make more money than they do today, but with low barriers of entry, the question you must answer is whether the value of a company's stock price will climb with the growth of these businesses and how will increased competition affect overall business?
Money managers, aka the professionals, are staying clear of the trade and will re-examine once euphoria wears off. Valuations are seen as "stupid" and that will prevent many of these stocks to price much higher without investment and price support from billions of dollars. Although we have seen some big bought deals worth at least $35 million, this could bode well, but cuts short-term prices.
To quickly explain, a bought deal is when an investment bank or firm secures shares from the company. However, the investing client is given a discount to the market price and they then attempt to sell shares to their clients or in the stock market. This could lead to a supply glut and undermine current strength.
Not all money managers are as concerned in the short-term. A Jacob Securities money manager believes and predicts "...there is a fundamental business to support here. People want recreational cannabis ... If you have a longer investing horizon then you’ll do fine — these stocks will be trading higher a year from now than where they are trading today."
Disclaimer: the author and its household do not own any nor are short stocks and industry related stocks mentioned in the above article and do not have any derivative positions.
